BIONOMICS LIMITED - AM

Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210

23 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

31 Jul 2023 06:00:00 By Nasdaq GlobeNewswire

Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth

03 Jul 2023 06:00:00 By Nasdaq GlobeNewswire

Bionomics to Present at Upcoming June Investor Conferences

15 Jun 2023 08:00:01 By Nasdaq GlobeNewswire

Bionomics Announces Upcoming Poster Presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

30 May 2023 06:00:00 By Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

28 Apr 2023 06:00:00 By Nasdaq GlobeNewswire

Bionomics Announces the Completion of Enrollment in Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

27 Apr 2023 06:00:00 By Nasdaq GlobeNewswire

Bionomics Reports Promising Full Results Analysis from PREVAIL Phase 2 Study of BNC210 Social Anxiety Disorder (SAD)

08 Mar 2023 19:00:30 By Nasdaq GlobeNewswire

Bionomics’ Half-Year Report

23 Feb 2023 06:00:00 By Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

30 Jan 2023 18:23:46 By Nasdaq GlobeNewswire

Bionomics Reports Topline Results in PREVAIL Phase 2 Study of BNC210 in Social Anxiety Disorder

18 Dec 2022 19:34:26 By Nasdaq GlobeNewswire

Bionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive Officer

15 Dec 2022 18:35:25 By Nasdaq GlobeNewswire

Bionomics Announces Accepted Abstract and Upcoming Poster Presentations at the American College of Neuropsychopharmacology (ACNP) 2022 Annual Meeting

02 Dec 2022 06:00:00 By Nasdaq GlobeNewswire

Bionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in the United States

21 Nov 2022 18:13:51 By Nasdaq GlobeNewswire

Bionomics Limited Announces Pricing of Underwritten Offering of American Depositary Shares in the United States

16 Nov 2022 18:36:15 By Nasdaq GlobeNewswire

Bionomics Limited to Participate in Upcoming November Investor Conferences

02 Nov 2022 06:00:00 By Nasdaq GlobeNewswire

Quarterly Activities Report for September 2022

25 Oct 2022 06:00:00 By Nasdaq GlobeNewswire

Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million

18 Oct 2022 06:00:00 By Nasdaq GlobeNewswire

Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference

04 Oct 2022 06:00:00 By Nasdaq GlobeNewswire

Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder

21 Sep 2022 06:00:00 By Nasdaq GlobeNewswire